Skip to main content

Palliative pelvic exenteration for patients with gynecological malignancies

Archives of Gynecology and Obstetrics volume 283, pages 1107–1112 (2011)Cite this article

Abstract

Purpose

To evaluate the results of palliative pelvic exenteration in patients with gynecologic tumors.

Methods

A retrospective analysis was carried out in 13 patients from January 2000 to December 2007. The procedure was considered palliative because of distant metastatic disease or unresectable pelvic wall disease. Patients presented with bleeding, fistula, malodorous discharge or untreatable pain.

Result

Overall complication rate was 38.4%. Mean follow-up time was 8 months. Actuarial 2 years overall survival was 15.4%. Six patients survived more than 5 months and three more than 12 months. All achieved symptoms control and favorable impact in quality of life. Two patients are with stable disease after 26 and 28 months.

Conclusions

Palliative exenteration is a procedure with high morbidity and mortality rates and should only be offered to highly selected patients. The role of exenterative surgery in relieving severe symptoms in patients with incurable disease is yet to be established.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Höckel M, Dornhöfer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7(10):837–847

    PubMed  Article  Google Scholar 

  2. Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma. Cancer 1:177–183

    PubMed  Article  CAS  Google Scholar 

  3. Berek JS, Howe C, Lagasse LD, Hacker NF (2005) Pelvic exenteration for recurrent gynaecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99(1):1539

    Article  Google Scholar 

  4. Höckel M (2003) Laterally extended endopelvic resection—novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol 91:369–377

    PubMed  Article  Google Scholar 

  5. Houvenaeghel G, Moutardier V, Karsenty G, Bladou F, Lelong B, Buttarelli M et al (2004) Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol 92:680–683

    PubMed  Article  CAS  Google Scholar 

  6. Ketcham AS, Deckers PJ, Sugarbaker EV, Hoye RC, Thomas LB, Smith RR (1970) Pelvic exenteration for carcinoma of the uterine cervix—a 15-year experience. Cancer 26(3):513–521

    PubMed  Article  CAS  Google Scholar 

  7. Lawhead RA, Clark DGC, Smith DH, Pierce VK, Lewis JL (1989) Pelvic exenteration for recurrent or persistent gynaecologic malignancies: a 10-year review of the Memorial-Sloan-Kettering Cancer Center experience (1972–1981). Gynecol Oncol 33:279–282

    PubMed  Article  Google Scholar 

  8. Magrina JF, Stanhope CR, Waever AL (1997) Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol 64:130–135

    PubMed  Article  CAS  Google Scholar 

  9. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA (1989) Pelvic exenteration, university of Michigan: 100 patients at 5 years. Obstet Gynecol 74:934–943

    PubMed  CAS  Google Scholar 

  10. Saunders N (1995) Pelvic exenteration: by whom and for whom? Lancet 345:5–6

    PubMed  Article  CAS  Google Scholar 

  11. Sharma S, Odunsi K, Driscoll D, Lele S (2005) Pelvic exenteration for gynecological malignancies: twenty-year experience at Rosewell Park Cancer Institute. Int J Gynecol Cancer 15:475–482

    PubMed  Article  CAS  Google Scholar 

  12. Shingelton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM (1989) Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73:1027–1034

    Article  Google Scholar 

  13. Stanhope CR, Symmonds RE (1985) Palliative exenteration—what, when, and why? Am J Obstet Gynecol 152:12–16

    PubMed  CAS  Google Scholar 

  14. Symmonds RE, Pratt JH, Webb MJ (1975) Exenterative operations: experience with 198 patients. Am J Obstet Gynecol 121(7):907–918

    PubMed  CAS  Google Scholar 

  15. Guimaraes GC, Ferreira FO, Rossi BM, Aguiar S Jr, Zequi SC, Bachega W, Nakagawa WT, Fonseca FP, Sarkis AS, Lopes A (2006) Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution. J Surg Oncol 93(3):206–211

    PubMed  Article  Google Scholar 

  16. Lambrou NC, Pearson JM, Averette HE (2005) Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations. Surg Oncol Clin N Am 14:289–300

    PubMed  Article  Google Scholar 

  17. Rutledge FN, Smith JP, Wharton JT, O’Quinn AG (1977) Pelvic exenteration: analysis of 296 patients. Am J Obstet Gynecol 129:881–892

    PubMed  CAS  Google Scholar 

  18. McCahill LE, Krouse R, Chu D, Juarez G, Uman G, Ferrell B et al (2002) Indications and use of palliative surgery–results of Society of Surgical Oncology survey. Ann Surg Oncol 9:104–112

    PubMed  Article  Google Scholar 

  19. Easson A (2005) Successful surgical palliation: how do we define it, and how do we measure it? Am Coll Surg 200:117–120

    Google Scholar 

  20. World Health Organization (WHO) (1990) Analgesic Ladder, Clinical Practice Guideline. No. 9, pp 41–45, http://www.who.int/cancer/palliative/en/

  21. Hofmann B, Håheim LL, Søreide JA (2005) Ethics of palliative surgery in patients with cancer. Br J Surg 92(7):802–809

    PubMed  Article  CAS  Google Scholar 

  22. Dunn GP (2002) Surgical palliation in advanced disease: recent developments. Curr Oncol Rep 4:233–241

    PubMed  Article  Google Scholar 

  23. McCahill LE, Smith DD, Borneman T, Juarez G, Cullinane C, Chu DZJ (2003) A prospective evaluation of palliative outcomes for surgery of advanced malignancies. Ann Surg Oncol 10:654–663

    PubMed  Article  Google Scholar 

  24. Miner TJ, Jaques DP, Tavaf-Motamen H, Shriver C (1999) Decision making on surgical palliation based on patient outcome data. Am J Surg 177(2):150–154

    PubMed  Article  CAS  Google Scholar 

  25. Marnitz S, Kohler C, Muller M et al (2006) Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol 103:1023–1030

    PubMed  Article  Google Scholar 

  26. Long HJ, Bundy BN, Grendys EC Jr, Benda JA, McMeekin DS, Sorosky J et al (2005) Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 23:4626–4633

    PubMed  Article  CAS  Google Scholar 

  27. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J et al (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 22(15):3113–3119

    PubMed  Article  CAS  Google Scholar 

  28. Tambaro R, Scambia G, DiMaio M, Pisano C, Barletta E, Iaffaioli VR, Pignata S (2004) The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer. Crit Rev Oncol Hematol 52:33–44

    PubMed  Google Scholar 

  29. Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ (2005) Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience. Gynecol Oncol 98:54–58

    PubMed  Article  CAS  Google Scholar 

  30. Beachamp TL, Childress JF (2001) Principles of biomedical ethics. Oxford University Press, New York

    Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Affiliations

  1. Department of Pelvic Surgery, A. C. Camargo Cancer Hospital, Rua Prof. Antonio Prudente, 211, Liberdade, São Paulo, SP, 01509-010, Brazil

    Gustavo Cardoso Guimarães, Fabio Oliveira Ferreira, Samuel Aguiar, Benedito Mauro Rossi & Ademar Lopes

  2. Department of Gynecology, A. C. Camargo Cancer Hospital, Rua Prof. Antonio Prudente, 211, Liberdade, São Paulo, SP, 01509-010, Brazil

    Glauco Baiocchi, Lillian Yuri Kumagai & Carlos Chaves Fallopa

  3. Pathology Department, A. C. Camargo Cancer Hospital, Rua Prof. Antonio Prudente, 211, Liberdade, São Paulo, SP, 01509-010, Brazil

    Fernando Augusto Soares

Authors
  1. Gustavo Cardoso Guimarães
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glauco Baiocchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fabio Oliveira Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lillian Yuri Kumagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlos Chaves Fallopa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samuel Aguiar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Benedito Mauro Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fernando Augusto Soares
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ademar Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gustavo Cardoso Guimarães.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Guimarães, G.C., Baiocchi, G., Ferreira, F.O. et al. Palliative pelvic exenteration for patients with gynecological malignancies. Arch Gynecol Obstet 283, 1107–1112 (2011). https://doi.org/10.1007/s00404-010-1544-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-010-1544-8

Keywords

  • Pelvic exenteration
  • Gynecologic neoplasm
  • Palliative surgery
  • Palliative treatment